Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/794,288external-prioritypatent/US5580953A/en
Application filed by Amylin Pharmaceuticals IncfiledCriticalAmylin Pharmaceuticals Inc
Publication of NO932604D0publicationCriticalpatent/NO932604D0/no
Publication of NO932604LpublicationCriticalpatent/NO932604L/no
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Abstract
Forbindelser som inhiberer amylinaktivitet er tilveiebragt. Disse forbindelser kan anvendes ved behandling av tilstander hvor det er fordelaktig å redusere amylinaktivitet, inklu- derende behandlingen av type 2 diabetes mellitus, nedsatt glukosetoleranse, fedme og insulinresistens. 'Lys-Cys-Asn-Thr^Ala-Thr-Cys-Ala-Thr-^GIn-Arg-leu- Ala-Asn-'5Phe-Leu-Val-His-Ser-20Ser-Asn-Asn-Phe-Gly- J5Ala-lle-Leu-Ser-Ser-3t>Thr-Asn-Val-GlY-Ser-35Asn-Thr- Tyr-(NHj)
NO93932604A1991-11-191993-07-19Nye amylinantagonispeptider og deres anvendelse
NO932604L
(no)